PLGA公司
乙醇酸
药物输送
乳酸
微粒
药品
生物利用度
化学
毒品携带者
微球
可生物降解聚合物
活性成分
靶向给药
纳米技术
药理学
聚合物
材料科学
有机化学
生物化学
医学
纳米颗粒
化学工程
体外
细菌
工程类
生物
遗传学
作者
Antonios Vlachopoulos,Georgia Karlioti,Evangelia Balla,Vasileios Daniilidis,Theocharis Kalamas,Myrika Stefanidou,Nikolaos D. Bikiaris,Evi Christodoulou,Ioanna Koumentakou,Evangelos Karavas,Dimitrios N. Bikiaris
出处
期刊:Pharmaceutics
[MDPI AG]
日期:2022-02-04
卷期号:14 (2): 359-359
被引量:67
标识
DOI:10.3390/pharmaceutics14020359
摘要
The sustained release of pharmaceutical substances remains the most convenient way of drug delivery. Hence, a great variety of reports can be traced in the open literature associated with drug delivery systems (DDS). Specifically, the use of microparticle systems has received special attention during the past two decades. Polymeric microparticles (MPs) are acknowledged as very prevalent carriers toward an enhanced bio-distribution and bioavailability of both hydrophilic and lipophilic drug substances. Poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), and their copolymers are among the most frequently used biodegradable polymers for encapsulated drugs. This review describes the current state-of-the-art research in the study of poly(lactic acid)/poly(lactic-co-glycolic acid) microparticles and PLA-copolymers with other aliphatic acids as drug delivery devices for increasing the efficiency of drug delivery, enhancing the release profile, and drug targeting of active pharmaceutical ingredients (API). Potential advances in generics and the constant discovery of therapeutic peptides will hopefully promote the success of microsphere technology.
科研通智能强力驱动
Strongly Powered by AbleSci AI